Chemical angioplasty vs. balloon plus chemical angioplasty for delayed cerebral ischemia: a pilot study of PbtO
Angioplasty
Brain tissue oxygen
Delayed cerebral ischaemia
Vasospasm
Journal
Acta neurochirurgica
ISSN: 0942-0940
Titre abrégé: Acta Neurochir (Wien)
Pays: Austria
ID NLM: 0151000
Informations de publication
Date de publication:
16 Apr 2024
16 Apr 2024
Historique:
received:
31
10
2023
accepted:
29
03
2024
medline:
17
4
2024
pubmed:
17
4
2024
entrez:
16
4
2024
Statut:
epublish
Résumé
Delayed cerebral ischaemia (DCI) is a major cause of morbidity and mortality after aneurysmal subarachnoid haemorrhage (aSAH). Chemical angioplasty (CA) and transluminal balloon angioplasty (TBA) are used to treat patients with refractory vasospasm causing DCI. Multi-modal monitoring including brain tissue oxygenation (PbtO Retrospective case series of patients with DCI who had PbtO There were immediate significant improvements in PbtO Combined balloon plus chemical angioplasty results in more sustained improvement in brain tissue oxygenation compared with chemical angioplasty alone. Our findings suggest that PbtO
Sections du résumé
BACKGROUND
BACKGROUND
Delayed cerebral ischaemia (DCI) is a major cause of morbidity and mortality after aneurysmal subarachnoid haemorrhage (aSAH). Chemical angioplasty (CA) and transluminal balloon angioplasty (TBA) are used to treat patients with refractory vasospasm causing DCI. Multi-modal monitoring including brain tissue oxygenation (PbtO
METHODS
METHODS
Retrospective case series of patients with DCI who had PbtO
RESULTS
RESULTS
There were immediate significant improvements in PbtO
CONCLUSION
CONCLUSIONS
Combined balloon plus chemical angioplasty results in more sustained improvement in brain tissue oxygenation compared with chemical angioplasty alone. Our findings suggest that PbtO
Identifiants
pubmed: 38627273
doi: 10.1007/s00701-024-06066-2
pii: 10.1007/s00701-024-06066-2
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
179Informations de copyright
© 2024. The Author(s).
Références
Bejjani GK, Bank WO, Olan WJ, Sekhar LN (1998) The efficacy and safety of angioplasty for cerebral vasospasm after subarachnoid hemorrhage. Neurosurgery 42(5):979–86
doi: 10.1097/00006123-199805000-00013
pubmed: 9588541
Budohoski KP, Guilfoyle M, Helmy A, Huuskonen T, Czosnyka M, Kirollos R, Menon DK, Pickard JD, Kirkpatrick PJ (2014) The pathophysiology and treatment of delayed cerebral ischaemia following subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 85(12):1343–1353
doi: 10.1136/jnnp-2014-307711
pubmed: 24847164
Craven CL, Sae-Huang M, Hoskote C, Watkins LD, Reddy U, Toma AK (2021) Relationship between brain tissue oxygen tension and transcranial Doppler ultrasonography. World Neurosurg 149:e942–e946
doi: 10.1016/j.wneu.2021.01.070
pubmed: 33513443
Deshaies EM, Jacobsen W, Singla A, Li F, Gorji R (2012) Brain tissue oxygen monitoring to assess reperfusion after intra-arterial treatment of aneurysmal subarachnoid hemorrhage−induced cerebral vasospasm: a retrospective study. AJNR Am J Neuroradiol 33(7):1411–1415
doi: 10.3174/ajnr.A2971
pubmed: 22422178
pmcid: 7965503
Dodd WS, Laurent D, Dumont AS, Hasan DM, Jabbour PM, Starke RM, Hosaka K, Polifka AJ, Hoh BL, Chalouhi N (2021) Pathophysiology of delayed cerebral ischemia after subarachnoid hemorrhage: a review. J Am Heart Assoc 10(15):e021845
doi: 10.1161/JAHA.121.021845
pubmed: 34325514
pmcid: 8475656
Elliott JP, Newell DW, Lam DJ, Eskridge JM, Douville CM, Le Roux PD, Lewis DH, Mayberg MR, Grady MS, Winn HR (1998) Comparison of balloon angioplasty and papaverine infusion for the treatment of vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 88(2):277–284
doi: 10.3171/jns.1998.88.2.0277
pubmed: 9452236
Fandino J, Kaku Y, Schuknecht B, Valavanis A, Yonekawa Y (1998) Improvement of cerebral oxygenation patterns and metabolic validation of superselective intraarterial infusion of papaverine for the treatment of cerebral vasospasm. J Neurosurg 89(1):93–100
doi: 10.3171/jns.1998.89.1.0093
pubmed: 9647178
Hoelper BM, Hofmann E, Sporleder R, Soldner F, Behr R (2003) Transluminal balloon angioplasty improves brain tissue oxygenation and metabolism in severe vasospasm after aneurysmal subarachnoid hemorrhage: case report. Neurosurgery 52(4):970–4
doi: 10.1227/01.NEU.0000053033.98317.A3
pubmed: 12657196
Hoh BL, Ogilvy CS (2005) Endovascular treatment of cerebral vasospasm: transluminal balloon angioplasty, intra-arterial papaverine, and intra-arterial nicardipine. Neurosurg Clin N Am 16(3):501–16
doi: 10.1016/j.nec.2005.04.004
pubmed: 15990041
Labeyrie M-A, Gaugain S, Boulouis G, Zetchi A, Brami J, Saint-Maurice J-P, Civelli V, Froelich S, Houdart E (2019) Distal balloon angioplasty of cerebral vasospasm decreases the risk of delayed cerebral infarction. AJNR Am J Neuroradiol 40(8):1342–1348
doi: 10.3174/ajnr.A6124
pubmed: 31320465
pmcid: 7048486
Luer MS, Dujovny M, Slavin KV, Hernandez-Avila G, Ausman JI (1995) Regional cerebral oxygen saturation during intra-arterial papaverine therapy for vasospasm: case report. Neurosurgery 36(5):1033–1036
doi: 10.1227/00006123-199505000-00024
pubmed: 7791970
Meng L, Settecase F, Xiao J, Yu Z, Flexman AM, Higashida RT (2016) Initial clinical experience with near-infrared spectroscopy in assessing cerebral tissue oxygen saturation in cerebral vasospasm before and after intra-arterial verapamil injection. J Clin Neurosci 26:63–69
doi: 10.1016/j.jocn.2015.10.020
pubmed: 26765758
Polin RS, Coenen VA, Hansen CA, Shin P, Baskaya MK, Nanda A, Kassell NF (2000) Efficacy of transluminal angioplasty for the management of symptomatic cerebral vasospasm following aneurysmal subarachnoid hemorrhage. J Neurosurg 92(2):284–290
doi: 10.3171/jns.2000.92.2.0284
pubmed: 10659016
Rabinstein AA, Friedman JA, Weigand SD, McClelland RL, Fulgham JR, Manno EM, Atkinson JLD, Wijdicks EFM (2004) Predictors of cerebral infarction in aneurysmal subarachnoid hemorrhage. Stroke 35(8):1862–1866
doi: 10.1161/01.STR.0000133132.76983.8e
pubmed: 15218156
Ramakrishna R, Stiefel M, Udoetuk J, Spiotta A, Levine JM, Kofke WA, Zager E, Yang W, Leroux P (2008) Brain oxygen tension and outcome in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 109(6):1075–1082
doi: 10.3171/JNS.2008.109.12.1075
pubmed: 19035722
Rasmussen R, Bache S, Stavngaard T, Skjøth-Rasmussen J, Romner B (2015) Real-time changes in brain tissue oxygen during endovascular treatment of cerebral vasospasm. Acta Neurochir Suppl 120:183–186
pubmed: 25366621
Rosenwasser RH, Armonda RA, Thomas JE, Benitez RP, Gannon PM, Harrop J (1999) Therapeutic modalities for the management of cerebral vasospasm: timing of endovascular options. Neurosurgery 44(5):975–9
doi: 10.1097/00006123-199905000-00022
pubmed: 10232530
Santillan A, Knopman J, Zink W, Patsalides A, Gobin YP (2011) Transluminal balloon angioplasty for symptomatic distal vasospasm refractory to medical therapy in patients with aneurysmal subarachnoid hemorrhage. Neurosurgery 69(1):95–101
doi: 10.1227/NEU.0b013e31821424f9
pubmed: 21368694
Schacht H, Küchler J, Boppel T, Leppert J, Ditz C, Schramm P, Neumann A (2020) Transluminal balloon angioplasty for cerebral vasospasm after spontaneous subarachnoid hemorrhage: a single-center experience. Clin Neurol Neurosurg 188:105590
doi: 10.1016/j.clineuro.2019.105590
pubmed: 31759310
Stiefel MF, Spiotta AM, Udoetuk JD, Maloney-Wilensky E, Weigele JB, Hurst RW, LeRoux PD (2006) Intra-arterial papaverine used to treat cerebral vasospasm reduces brain oxygen. Neurocrit Care 4(2):113–118
doi: 10.1385/NCC:4:2:113
pubmed: 16627898
Stuart RM, Helbok R, Kurtz P et al (2011) High-dose intra-arterial verapamil for the treatment of cerebral vasospasm after subarachnoid hemorrhage: prolonged effects on hemodynamic parameters and brain metabolism. Neurosurgery 68(2):337–45
doi: 10.1227/NEU.0b013e318201be47
pubmed: 21135735
Vergouwen MDI, Vermeulen M, van Gijn J et al (2010) Definition of delayed cerebral ischemia after aneurysmal subarachnoid hemorrhage as an outcome event in clinical trials and observational studies: proposal of a multidisciplinary research group. Stroke 41(10):2391–2395
doi: 10.1161/STROKEAHA.110.589275
pubmed: 20798370